Possible involvement of type 1 inositol 1,4,5-trisphosphate receptors up-regulated by dopamine D1 and D2 receptors in mouse nucleus accumbens neurons in the development of methamphetamine-induced place preference

Neuroscience

Volumn 227, Issue , 2012, Pages 22-29

  Kurokawa, K ^a   Mizuno, K ^a   Ohkuma, S ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

2 APB; Conditioned place preference; Dopamine receptors; Methamphetamine; Type 1 inositol 1, 4, 5 triphosphate receptors; Xestospongin C

Indexed keywords

2 AMINOPHENOXYETHANE BORATE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR 1; METHAMPHETAMINE; RACLOPRIDE; UNCLASSIFIED DRUG; XESTOSPONGIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; SINGLE DRUG DOSE;

ANALYSIS OF VARIANCE; ANIMALS; BORON COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MACROCYCLIC COMPOUNDS; METHAMPHETAMINE; MICE; MICROINJECTIONS; NERVE TISSUE PROTEINS; NEURONS; NUCLEUS ACCUMBENS; OXAZOLES; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; UP-REGULATION;

EID: 84867747124     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.09.029     Document Type: Article

References (26)

1. Ahn K.C., Bernier B.E., Harnett M.T., Morikawa H. IP3 receptor sensitization during in vivo amphetamine experience enhances NMDA receptor plasticity in dopamine neurons of the ventral tegmental area. J Neurosci 2010, 30:6689-6699.
2. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000, 1:11-21.
3. Che T., Sun H., Li J., Yu X., Zhu D., Xue B., Liu K., Zhang M., Kunze W., Liu C. Oxytocin hyperpolarizes cultured duodenum myenteric intrinsic primary afferent neurons by opening BK(Ca) channels through IP(3) pathway. J Neurochem 2012, 121:516-525.
4. Contreras-Ferrat A.E., Toro B., Bravo R., Parra V., Vasquez C., Ibarra C., Mears D., Chiong M., Jaimovich E., Klip A., Lavandero S. An inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes. Endocrinology 2010, 151:4665-4677.
5. Faure A.V., Grunwald D., Moutin M.J., Hilly M., Mauger J.P., Marty I., De Waard M., Villaz M., Albrieux M. Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex. Eur J Neurosci 2001, 14:1613-1622.
6. Fill M., Copello J.A. Ryanodine receptor calcium release channels. Physiol Rev 2002, 82:893-922.
7. 2+ release channels. Physiol Rev 2007, 87:593-658.
8. Graef I.A., Mermelstein P.G., Stankunas K., Neilson J.R., Deisseroth K., Tsien R.W., Crabtree G.R. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 1999, 401:703-708.
9. Groth R.D., Weick J.P., Bradley K.C., Luoma J.I., Aravamudan B., Klug J.R., Thomas M.J., Mermelstein P.G. D1 dopamine receptor activation of NFAT-mediated striatal gene expression. Eur J Neurosci 2008, 27:31-42.
10. Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., Celio M.R. Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains 2000, Elsevier.
11. Jayanthi S., Deng X., Ladenheim B., McCoy M.T., Cluster A., Cai N.S., Cadet J.L. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci USA 2005, 102:868-873.
12. Kurokawa K., Mizuno K., Shibasaki M., Ohkuma S. Regulation of ryanodine receptors by dopamine D(1) receptors during methamphetamine-induced place conditioning. J Neurochem 2010, 115:1206-1214.
13. Kurokawa K., Mizuno K., Kiyokage E., Shibasaki M., Toida K., Ohkuma S. Dopamine D(1) receptor signaling system regulates ryanodine receptor expression after intermittent exposure to methamphetamine in primary cultures of midbrain and cerebral cortical neurons. J Neurochem 2011, 118:773-783.
14. Kurokawa K., Mizuno K., Shibasaki M., Ohkuma S. Dopamine D(1) receptors participate in cocaine-induced place preference via regulation of ryanodine receptor expression. J Pharmacol Sci 2011, 117:87-97.
15. Kurokawa K., Mizuno K., Ohkuma S. Increase of ryanodine receptors by dopamine D1 receptors is negatively regulated by gamma-aminobutyric acid type B receptors in primary cultures of mouse cerebral cortical neurons. J Neurosci Res 2012, 90:1626-1638.
16. Kurokawa K., Mizuno K., Shibasaki M., Ohkuma S. Regulation of type 1 inositol 1,4,5-triphosphate receptor by dopamine receptors in cocaine-induced place conditioning. Synapse 2012, 66:180-186.
17. 2+ signaling. Curr Opin Neurobiol 1997, 7:339-345.
18. 2+ channel and its cellular function. Biochem Soc Symp 2007, 74:9-22.
19. Mizoguchi H., Yamada K., Mizuno M., Mizuno T., Nitta A., Noda Y., Nabeshima T. Regulations of methamphetamine reward by extracellular signal-regulated kinase 1/2/ets-like gene-1 signaling pathway via the activation of dopamine receptors. Mol Pharmacol 2004, 65:1293-1301.
20. Mizuno K., Kurokawa K., Ohkuma S. Dopamine D1 receptors regulate type 1 inositol 1,4,5-trisphosphate receptor expression via both AP-1- and NFATc4-mediated transcriptional processes. J Neurochem 2012, 122:702-713.
21. Nestler E.J. Is there a common molecular pathway for addiction?. Nat Neurosci 2005, 8:1445-1449.
22. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
23. 2+ release. Invest Ophthalmol Vis Sci 2011, 52:3874-3879.
24. Verkhratsky A., Shmigol A. Calcium-induced calcium release in neurones. Cell Calcium 1996, 19:1-14.
25. Wise R.A., Hoffman D.C. Localization of drug reward mechanisms by intracranial injections. Synapse 1992, 10:247-263.
26. Zhang X.J., Liu L.L., Jiang S.X., Zhong Y.M., Yang X.L. Activation of the sigma receptor 1 suppresses NMDA responses in rat retinal ganglion cells. Neuroscience 2011, 177:12-22.